Management of hydrocephalus in infancy

Use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts

Shlomo Shinnar, Karen Gammon, Eldo W. Bergman, Melvin Epstein, John M. Freeman

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Despite its effectiveness, cerebrospinal shunting for hydrocephalus continues to be accompanied by considerable complications and morbidity. Medical therapy with acetazolamide 100 mg/kg/day and furosemide 1 mg/kg/day can be an effective alteraative to shunting by halting progression of hydrocephalus until such time as sutures can become fibrosed and spontaneous arrest can occur. In an appropriately selected population older than 2 weeks with hydrocephalus of varied origin, our success rate in avoiding shunting is >50%. The dramatic difference between the number of hospitalizations of patients with shunts and those treated medically, and the potential to avoid shunt dependence would appear to make an initial trial with medical therapy worthwhile.

Original languageEnglish (US)
Pages (from-to)31-37
Number of pages7
JournalThe Journal of Pediatrics
Volume107
Issue number1
DOIs
StatePublished - 1985
Externally publishedYes

Fingerprint

Cerebrospinal Fluid Shunts
Acetazolamide
Furosemide
Hydrocephalus
Sutures
Hospitalization
Morbidity
Therapeutics
Population

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Management of hydrocephalus in infancy : Use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts. / Shinnar, Shlomo; Gammon, Karen; Bergman, Eldo W.; Epstein, Melvin; Freeman, John M.

In: The Journal of Pediatrics, Vol. 107, No. 1, 1985, p. 31-37.

Research output: Contribution to journalArticle

Shinnar, Shlomo ; Gammon, Karen ; Bergman, Eldo W. ; Epstein, Melvin ; Freeman, John M. / Management of hydrocephalus in infancy : Use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts. In: The Journal of Pediatrics. 1985 ; Vol. 107, No. 1. pp. 31-37.
@article{90fc4b1e7ece4c07ab7afb73645c4a28,
title = "Management of hydrocephalus in infancy: Use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts",
abstract = "Despite its effectiveness, cerebrospinal shunting for hydrocephalus continues to be accompanied by considerable complications and morbidity. Medical therapy with acetazolamide 100 mg/kg/day and furosemide 1 mg/kg/day can be an effective alteraative to shunting by halting progression of hydrocephalus until such time as sutures can become fibrosed and spontaneous arrest can occur. In an appropriately selected population older than 2 weeks with hydrocephalus of varied origin, our success rate in avoiding shunting is >50{\%}. The dramatic difference between the number of hospitalizations of patients with shunts and those treated medically, and the potential to avoid shunt dependence would appear to make an initial trial with medical therapy worthwhile.",
author = "Shlomo Shinnar and Karen Gammon and Bergman, {Eldo W.} and Melvin Epstein and Freeman, {John M.}",
year = "1985",
doi = "10.1016/S0022-3476(85)80609-0",
language = "English (US)",
volume = "107",
pages = "31--37",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Management of hydrocephalus in infancy

T2 - Use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts

AU - Shinnar, Shlomo

AU - Gammon, Karen

AU - Bergman, Eldo W.

AU - Epstein, Melvin

AU - Freeman, John M.

PY - 1985

Y1 - 1985

N2 - Despite its effectiveness, cerebrospinal shunting for hydrocephalus continues to be accompanied by considerable complications and morbidity. Medical therapy with acetazolamide 100 mg/kg/day and furosemide 1 mg/kg/day can be an effective alteraative to shunting by halting progression of hydrocephalus until such time as sutures can become fibrosed and spontaneous arrest can occur. In an appropriately selected population older than 2 weeks with hydrocephalus of varied origin, our success rate in avoiding shunting is >50%. The dramatic difference between the number of hospitalizations of patients with shunts and those treated medically, and the potential to avoid shunt dependence would appear to make an initial trial with medical therapy worthwhile.

AB - Despite its effectiveness, cerebrospinal shunting for hydrocephalus continues to be accompanied by considerable complications and morbidity. Medical therapy with acetazolamide 100 mg/kg/day and furosemide 1 mg/kg/day can be an effective alteraative to shunting by halting progression of hydrocephalus until such time as sutures can become fibrosed and spontaneous arrest can occur. In an appropriately selected population older than 2 weeks with hydrocephalus of varied origin, our success rate in avoiding shunting is >50%. The dramatic difference between the number of hospitalizations of patients with shunts and those treated medically, and the potential to avoid shunt dependence would appear to make an initial trial with medical therapy worthwhile.

UR - http://www.scopus.com/inward/record.url?scp=0021843935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021843935&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(85)80609-0

DO - 10.1016/S0022-3476(85)80609-0

M3 - Article

VL - 107

SP - 31

EP - 37

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 1

ER -